Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial Article

Industry Collaboration International Collaboration

cited authors

  • Lee, Jung-Min; Moore, Richard G.; Ghamande, Sharad; Park, Min S.; Diaz, John P.; Chapman, Julia; Kendrick, James; Slomovitz, Brian M.; Tewari, Krishnansu S.; Lowe, Elizabeth S.; Milenkova, Tsveta; Kumar, Sanjeev; Dymond, Mike; Brown, Jessica; Liu, Joyce F.

authors

Publication Date

  • October 3, 2022

webpage

published in

category

start page

  • 4186

end page

  • 4193

volume

  • 28

issue

  • 19